Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Redlands › NPI 1043354111
Hospital

Redlands Community Hospital

Redlands Community Hospital was paid $38.40M by Medicaid between Jan 2018 and Nov 2024, across 280 billing codes. Its largest line is 0450, Emergency room services — 9.7% of everything it billed.

33Billing provider infoREDLANDS COMMUNITY HOSPITAL
REDLANDS, CA 92373
33aNPI1043354111assigned 02/20/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$38.40M
24GClaims1,135,005
24DCodes billed280
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#74 of 410
Median peer was paid$6.90M
This provider vs. median5.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018177,145$4.96M
2019152,471$4.40M
2020125,957$3.87M
2021147,094$5.06M
2022178,097$6.68M
2023189,416$7.30M
2024incomplete164,825$6.14M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 9.7% 69,258 54,636 $3.71M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 6.7% 45,456 40,221 $2.58M
L8699 Prosthetic implant, not otherwise specified 5.6% 497 489 $2.14M
0202U Oncology (prostate), multianalyte, gene expression profiling 5.2% 5,778 5,697 $1.98M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 4.3% 26,386 23,328 $1.65M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.8% 7,129 6,694 $1.46M
70450 Computed tomography, head or brain; without contrast material 3.7% 8,967 8,280 $1.40M
99070 3.4% 93,734 38,578 $1.31M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.7% 35,033 30,563 $1.02M
93975 2.3% 2,492 2,330 $896K
80053 Comprehensive metabolic panel 2.3% 48,466 41,236 $887K
0510 2.2% 22,501 19,393 $837K
268 more codes
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.1% 65,090 $807K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.7% 11,026 $639K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.7% 4,802 $638K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.5% 16,795 $582K
99285 Emergency room visit (most serious) 1.3% 3,935 $502K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.2% 18,165 $467K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.2% 7,197 $463K
99284 Emergency room visit (serious) 1.2% 4,941 $445K
77067 Screening mammography, bilateral, including computer-aided detection 1.1% 2,997 $416K
76830 Ultrasound, transvaginal 1.1% 5,441 $414K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.1% 5,376 $411K
84484 1.0% 24,987 $393K
Z7502 <1% 10,143 $383K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 5,041 $383K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,338 $353K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 14,723 $352K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 5,617 $348K
0762 <1% 4,589 $338K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,451 $332K
Q3014 Telehealth originating site facility fee <1% 12,951 $322K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,496 $312K
71045 Radiologic examination, chest; single view <1% 20,787 $309K
96375 Therapeutic injection; each additional sequential IV push <1% 9,562 $289K
72125 Computed tomography, cervical spine; without contrast material <1% 1,517 $270K
80048 Basic metabolic panel (calcium, ionized) <1% 17,581 $241K
71046 Radiologic examination, chest; 2 views <1% 8,792 $238K
83690 <1% 22,375 $225K
76801 <1% 3,476 $222K
93971 <1% 2,285 $222K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 5,056 $219K
J3490 Unclassified drugs <1% 28,911 $207K
0370 <1% 1,285 $199K
99499 <1% 3,058 $185K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,748 $178K
G0378 Hospital observation service, per hour <1% 2,354 $160K
81001 <1% 31,461 $154K
99221 <1% 909 $154K
87040 <1% 4,780 $145K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,378 $141K
93970 <1% 810 $133K
76642 <1% 1,498 $131K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 9,710 $130K
99213 Doctor's office visit, returning patient (routine) <1% 3,341 $124K
84443 Thyroid stimulating hormone (TSH) <1% 5,247 $121K
84703 <1% 10,635 $119K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 5,033 $118K
83605 <1% 7,180 $114K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 764 $110K
84702 <1% 5,936 $103K
83036 Hemoglobin; glycosylated (A1C) <1% 6,172 $102K
81025 <1% 12,769 $99K
73564 <1% 2,382 $96K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,451 $96K
85730 <1% 12,438 $95K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,708 $94K
72110 <1% 1,897 $90K
83880 <1% 4,429 $88K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,544 $85K
76770 <1% 1,115 $84K
83735 <1% 9,575 $81K
87086 Culture, bacterial; quantitative colony count, urine <1% 9,475 $80K
J1815 Injection, insulin, per 5 units <1% 1,021 $71K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,174 $69K
Z9725 <1% 2,350 $68K
0720 <1% 1,721 $65K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 430 $64K
85610 <1% 13,104 $64K
73630 <1% 2,484 $62K
97803 <1% 800 $61K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,232 $60K
74022 <1% 1,417 $58K
70486 <1% 225 $57K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 837 $56K
87186 <1% 3,725 $54K
73610 <1% 2,080 $54K
82550 <1% 6,166 $52K
73030 <1% 1,953 $51K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,886 $51K
73130 <1% 1,727 $48K
0710 <1% 1,409 $46K
96361 Intravenous infusion, hydration; each additional hour <1% 1,271 $46K
90715 <1% 1,490 $44K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,898 $44K
84439 <1% 3,532 $43K
86920 <1% 177 $40K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 458 $40K
84145 <1% 2,077 $39K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,668 $38K
86901 <1% 6,192 $36K
86850 <1% 3,344 $36K
72050 <1% 829 $35K
85379 <1% 2,308 $34K
72131 <1% 216 $33K
73110 <1% 1,273 $33K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 559 $32K
87070 <1% 2,461 $32K
99238 Hospital discharge day management, 30 minutes or less <1% 1,019 $31K
71250 <1% 194 $31K
74018 <1% 1,393 $31K
77066 Tomosynthesis, mammo <1% 247 $31K
H1003 Prenatal care, at-risk enhanced service; education <1% 1,368 $29K
85027 <1% 2,804 $29K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 233 $28K
87088 <1% 3,741 $27K
82553 <1% 1,528 $27K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 362 $26K
0760 <1% 719 $26K
80143 <1% 1,681 $25K
84481 <1% 1,114 $25K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 301 $24K
80179 <1% 1,638 $24K
70496 <1% 100 $24K
70551 Magnetic resonance imaging, brain; without contrast material <1% 60 $24K
73502 <1% 724 $23K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,616 $23K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,300 $22K
P9016 Red blood cells, leukocytes reduced, each unit <1% 124 $22K
J1170 Injection, hydromorphone, up to 4 mg <1% 5,013 $22K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 255 $21K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 19,092 $20K
Z7500 <1% 575 $19K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 246 $19K
84100 <1% 3,723 $19K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 317 $19K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 621 $18K
76870 <1% 310 $18K
36415 Collection of venous blood by venipuncture <1% 10,028 $18K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,035 $17K
0011A <1% 480 $17K
70498 <1% 74 $16K
0942 <1% 455 $16K
80192 <1% 656 $16K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 457 $16K
99218 <1% 95 $16K
86140 <1% 2,378 $16K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 604 $14K
87077 <1% 1,748 $14K
80076 <1% 1,252 $14K
27447 <1% 14 $13K
86900 <1% 3,680 $13K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 382 $13K
87400 <1% 2,562 $13K
82805 <1% 328 $13K
J0690 Injection, cefazolin sodium, 500 mg <1% 2,401 $12K
0012A <1% 318 $12K
82948 <1% 2,143 $12K
94799 <1% 76 $12K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 4,850 $11K
73590 <1% 581 $11K
10060 <1% 390 $11K
73080 <1% 439 $11K
93350 <1% 158 $11K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,967 $11K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 11,190 $10K
12001 <1% 372 $10K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,319 $10K
J1644 Injection, heparin sodium, per 1000 units <1% 860 $10K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 5,887 $10K
85007 <1% 2,368 $10K
81003 <1% 2,957 $10K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,682 $9K
86403 <1% 523 $9K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 13 $8K
87205 <1% 1,406 $8K
87641 <1% 309 $8K
70491 <1% 28 $8K
96376 <1% 338 $8K
81002 <1% 1,441 $8K
73560 <1% 381 $8K
85651 <1% 1,783 $8K
82010 <1% 440 $8K
72072 <1% 226 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 4,191 $7K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,591 $7K
51701 <1% 245 $7K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 4,854 $7K
A4217 Sterile water/saline, 500 ml <1% 858 $6K
0270 <1% 984 $6K
Z6400 <1% 210 $6K
87075 <1% 336 $5K
87210 <1% 825 $5K
97802 <1% 38 $5K
0250 <1% 3,111 $5K
97039 <1% 317 $5K
82533 <1% 217 $5K
73140 <1% 288 $5K
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,139 $5K
J2704 Injection, propofol, 10 mg <1% 1,182 $5K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 154 $4K
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session <1% 252 $4K
77063 Screening digital breast tomosynthesis, bilateral <1% 81 $4K
J3370 Injection, vancomycin hcl, 500 mg <1% 272 $4K
72128 <1% 27 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 13 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 14 $3K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 4,788 $3K
76536 <1% 58 $3K
99217 <1% 106 $3K
77065 Tomosynthesis, mammo <1% 25 $3K
72100 <1% 114 $3K
82570 <1% 391 $3K
Z7610 <1% 1,448 $3K
82140 <1% 187 $3K
93017 <1% 38 $3K
0002A <1% 70 $3K
S0197 Prenatal vitamins, 30-day supply <1% 1,527 $2K
73090 <1% 116 $2K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 319 $2K
97116 <1% 100 $2K
J2060 Injection, lorazepam, 2 mg <1% 1,872 $2K
36600 <1% 193 $2K
0001A <1% 69 $2K
90632 <1% 30 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 174 $2K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 69 $2K
S0077 Injection, clindamycin phosphate, 300 mg <1% 158 $1K
J1650 Injection, enoxaparin sodium, 10 mg <1% 433 $1K
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 185 $1K
0258 <1% 388 $1K
94760 <1% 180 $1K
99401 <1% 99 $1K
99402 <1% 50 $1K
0272 <1% 188 $1K
82803 <1% 44 $1K
80061 Lipid panel <1% 75 $939.43
88300 <1% 263 $904.34
87420 <1% 63 $894.45
71101 <1% 26 $883.91
87581 <1% 14 $775.83
87486 <1% 14 $775.83
86592 <1% 133 $715.24
85018 <1% 160 $695.13
86703 <1% 45 $693.08
99214 Doctor's office visit, returning patient (more involved) <1% 12 $677.76
76819 Fetal biophysical profile; without non-stress testing <1% 16 $661.05
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 400 $637.20
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 34 $618.24
82607 <1% 51 $608.39
87807 <1% 65 $564.94
99201 <1% 12 $529.16
J3360 Injection, diazepam, up to 5 mg <1% 40 $508.88
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg <1% 146 $507.04
88342 <1% 12 $500.31
S9452 Nutrition classes, non-physician provider, per session <1% 17 $344.40
84550 <1% 57 $344.37
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 216 $287.34
J0456 Injection, azithromycin, 500 mg <1% 61 $263.68
H2000 Comprehensive multidisciplinary evaluation <1% 15 $246.00
82150 <1% 27 $245.35
82728 <1% 16 $236.90
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 103 $207.50
80164 <1% 12 $205.61
73660 <1% 13 $192.83
31720 <1% 15 $153.00
70360 <1% 12 $151.57
J7050 Infusion, normal saline solution, 250 cc <1% 92 $139.58
72170 <1% 12 $138.05
J0736 Injection, clindamycin phosphate, 300 mg <1% 31 $132.62
J1953 Injection, levetiracetam, 10 mg <1% 14 $95.00
83615 <1% 13 $81.60
82746 <1% 12 $81.08
J1630 Injection, haloperidol, up to 5 mg <1% 92 $74.07
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 15 $64.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 45 $44.50
0637 <1% 187 $39.18
J1940 Injection, furosemide, up to 20 mg <1% 14 $6.40
90853 Group psychotherapy (other than of a multiple-family group) 0% 485 $0.00
0100U 0% 22 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDADABHAI, SABI (CHIEF FINANCIAL OFFICER)